Australia reviewing plans for naming biosimilars

posted 23/01/2015

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), has changed its plans for naming biosimilars, ‘following recent international...

more
Biosimilar etanercept submitted for approval in EU Biosimilars/News | Posted 23/01/2015
Generics applications under review by EMA – Dec... Generics/General | Posted 23/01/2015
Filgrastim biosimilar has similar safety and ef... Biosimilars/Research | Posted 23/01/2015
Amgen’s approach in the biosimilars market Pharma News | Posted 23/01/2015
Prasco to market authorized colchicine generic... Generics/News | Posted 23/01/2015
UK outlines process for developing biosimilars... Policies & Legislation | Posted 23/01/2015
Mabion starts phase III trial for rituximab bio... Biosimilars/News | Posted 23/01/2015
Top 10 most read GaBI Online articles in 2014 Pharma News | Posted 16/01/2015
Patient perceptions of generics in Ireland Generics/Research | Posted 16/01/2015
Hospira submits application to FDA for epoetin... Biosimilars/News | Posted 16/01/2015
Biocomparable has comparable safety and efficac... Biosimilars/Research | Posted 16/01/2015
Apotex pegfilgrastim biosimilar under FDA review Biosimilars/News | Posted 16/01/2015
US judge invalidates 4 of 5 patents on Cubicin Generics/News | Posted 16/01/2015
Compromise reached on US legislation on biosimi... Policies & Legislation | Posted 16/01/2015
Biosimilars 2015 Conferences | Posted 16/01/2015
Extrapolation of indications in biosimilars: in... Biosimilars/Research | Posted 09/01/2015
FDA advisers recommend approval of filgrastim b... Biosimilars/News | Posted 09/01/2015
First infliximab ‘similar biologic’ launched in... Biosimilars/News | Posted 09/01/2015
GPhA comments on generics’ legislation and Tran... Generics/General | Posted 09/01/2015
Phase I study shows darbepoetin alfa biosimilar... Biosimilars/Research | Posted 09/01/2015
Generics makers to be penalized for huge price... Policies & Legislation | Posted 09/01/2015
Extrapolation of indications in biosimilars: ep... Biosimilars/Research | Posted 12/12/2014
Canada’s generics are too expensive Generics/Research | Posted 12/12/2014
Non-biological complex drug concept: experience... Biosimilars/Research | Posted 12/12/2014
Trade groups comment on China’s biosimilars gui... Policies & Legislation | Posted 12/12/2014
EU Member States suspend generics approvals due... Generics/General | Posted 12/12/2014
Momenta gains approval to start biosimilar adal... Biosimilars/News | Posted 12/12/2014
First celecoxib generics hit US market Generics/News | Posted 12/12/2014
EBG–Biosimilars 2015 Conferences | Posted 12/12/2014
US biosimilar uptake in the light of Obamacare Biosimilars/Research | Posted 05/12/2014
Irish pharmacists’ perceptions and attitudes to... Generics/Research | Posted 05/12/2014
Biosimilar infliximab launched in Japan Biosimilars/News | Posted 05/12/2014
Use of biosimilars in rheumatology Biosimilars/Research | Posted 05/12/2014
Generics makers challenging more patents Reports | Posted 05/12/2014
Stada to in-license adalimumab biosimilar Biosimilars/News | Posted 05/12/2014
FDA delays finalization of generics labelling rule Policies & Legislation | Posted 05/12/2014
Comparison of biosimilar filgrastim versus othe... Biosimilars/Research | Posted 28/11/2014
EuropaBio calls for distinguishable names for b... Biosimilars/General | Posted 28/11/2014
Generics losing out to brand-name drugs in Croatia Generics/Research | Posted 28/11/2014
Developments in the US over state biosimilars s... Policies & Legislation | Posted 28/11/2014
FDA withdraws automatic substitution of two met... Generics/News | Posted 28/11/2014
Amgen expands biosimilars programme Biosimilars/News | Posted 28/11/2014
Actavis buys Allergan and joins pharma top 10 Pharma News | Posted 28/11/2014
more